Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acorda Therapeutics (NQ: ACOR )

4.120 USD -0.090 (-2.14%)
Streaming Delayed Price Updated: 3:34 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Acorda Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on the launch of “A Taste for Life with Zarela℠”
Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on the launch of “A Taste for Life with Zarela”. 
From Business Wire News Releases
Acorda Therapeutics to Present at H.C. Wainwright Global Life Sciences Virtual Conference
Acorda Therapeutics to Present at H.C. Wainwright Global Life Sciences Virtual Conference 
From Business Wire News Releases
62 Biggest Movers From Friday
Gainers Sify Technologies Limited (NASDAQ: SIFY) surged 45.9% to close at $3.94 on Friday. Blackstone Group is in talks for ... 
Tags DBTX UBX BAOS
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Second Sight Medical (NASDAQ:EYES) stock rose 324.47% to $6.07 during Friday's regular session. As of 12:32 ... 
Tags CDXC IMRA Benzinga
From Benzinga
Friday Sector Laggards: Advertising, Biotechnology Stocks
In trading on Friday, advertising shares were relative laggards, down on the day by about 6.9%. Helping drag down the group were shares of Baosheng Media Group Holdings, down about 22% and shares of... 
Tags Stocks
From Market News Video
54 Stocks Moving In Friday's Mid-Day Session
Gainers XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) shares jumped 45% to $4.19 after dropping more than 10% on Thursday. W&T ... 
Tags News HKIB RELI
From Benzinga
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VRPX TLIS QURE
From Benzinga
11 Stocks Moving In Thursday's After-Hours Session
Gainers Ocular Therapeutics (NASDAQ: OCUL) shares are trading higher after the company announced the supplemental New Drug ... 
Tags News WTRH FLGT
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Fulgent Genetics (NASDAQ:FLGT) stock moved upwards by 29.19% to $110.5 during Thursday's after-market session. This ... 
Tags EVFM GBS TTOO
From Benzinga
Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags REGN NDRA Biotech
From Benzinga
Earnings Scheduled For March 4, 2021
Companies Reporting Before The Bell • Toro (NYSE:TTC) is expected to report quarterly earnings at $0.75 per share on ... 
Tags PRPL AHCO BZUN
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags ADAG Small Cap PFE
From Benzinga
Acorda Fourth Quarter/Year End 2020 Update: Webcast/Conference Call Scheduled for March 4, 2021
Acorda Fourth Quarter/Year End 2020 Update: Webcast/Conference Call Scheduled for March 4, 2021 
From Business Wire News Releases
Acorda Therapeutics Announces Departure of Chief, Business Operations
Acorda Therapeutics Announces Departure of Chief, Business Operations 
From Business Wire News Releases
Acorda Therapeutics Announces Completion of Sale of Manufacturing Operations to Catalent
Acorda Therapeutics Announces Completion of Sale of Manufacturing Operations to Catalent 
From Business Wire News Releases
77 Biggest Movers From Yesterday
Gainers Gritstone Oncology, Inc. (NASDAQ: GRTS) shares jumped 248.5% to close at $22.27 on Tuesday after the company announced ... 
Tags CRNT FRSX CLXT
From Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares climbed 164.3% to $15.54 after the company reported positive preliminary ... 
Tags GTH BLBD Trading Ideas
From Benzinga
80 Biggest Movers From Yesterday
Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a ... 
Tags WIMI VOLT APWC
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 33.02% to $5.64 during Wednesday's regular session. ... 
Tags Benzinga PRVB ACRX
From Benzinga
61 Stocks Moving In Wednesday's Mid-Day Session
Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares climbed 101.4% to $25.28 after the company swung to a profit in the ... 
Tags RPAY FWP NKLA
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock increased by 54.24% to $6.54 during Wednesday's pre-market session. ... 
Tags Market News AFIB ACOR
From Benzinga
Catalent Agrees to Acquire Dry Powder Inhaler Spray Drying, Capsule Manufacturing, and Packaging Capabilities from Acorda Therapeutics
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today... 
From PR Newswire
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GH ATRC DYN
From Benzinga
A Look Into Acorda Therapeutics's Debt
Shares of Acorda Therapeutics (NASDAQ:ACOR) moved higher by 2.42% in the past three months. Before having a look at the ... 
Tags Market News Intraday Update ACOR
From Benzinga
Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Offering Agree
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a definitive agreement to sell its INBRIJA manufacturing operations in Chelsea, Massachusetts to Catalent for $80... 
From Business Wire News Releases
Acorda Therapeutics to Present at 39th Annual J.P. Morgan Health Care Conference
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Health Care Conference on Thursday, January... 
From Business Wire News Releases
Acorda Therapeutics to Present at H.C. Wainwright BIOCONNECT Virtual Conference
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the January 11th -14th H.C. Wainwright BIOCONNECT Virtual Conference.... 
From Business Wire News Releases
74 Biggest Movers From Yesterday
Gainers Check-Cap Ltd. (NASDAQ: CHEK) shares surged 215.2% to close at $1.45 on Monday after gaining around 7% on Thursday. ... 
Tags PMVP Trading Ideas GATO
From Benzinga
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 286 stocks hit new 52-week highs. Areas of Interest: The company with the ... 
Tags CHX NEXA ORGO
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.